F. Bremsak

  • Citations Per Year
Learn More
Clinically used dosage regimen of nitroxoline, three times 100 mg daily, was proved to be inappropriate because the successfulness of medical treatment was rarely sufficient. Nitroxoline, used as urinary antiseptic, exhibits its antibacterial activity in concentrations higher than 6 mg/l, as demonstrated in many "in vitro" experiments. This work deals with(More)
For this study of dihydroergosine pharmacokinetic modelling and simulation, the data from our paper about3H-DHESN plasma, bile, urine, and faeces concentrations after intravenous and oral administration were used (1). The model obtained with the identified parameters was in agreement within vivo data. Certain special phenomena, such as the enterohepatic(More)
  • 1